MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0214450
Legacy Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.62 Cr
▲ 11% YoY
Net profit · FY 2024
₹17.22 Lakh
Net margin 3.7%
EBITDA · FY 2024
₹28.64 Lakh
EBITDA margin 6.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.5 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
29
Provident fund records
About Legacy Pharmaceuticals Private Limited
Data last updated:
Legacy Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2016PTC158159. Its GSTIN is 27AADCL0415G1ZX (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nilesh Sharadrao Aparajit and Dhananjay Dattatray Kulkarni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S No 166 Gajanan Nagar Phursungi, Pune, Maharashtra, India – 412307.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.62 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹17.22 Lakh (net margin 3.7%) and EBITDA of ₹28.64 Lakh (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years and 24% over five years.
The company has about 29 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.5 Cr on record.
Legacy Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0214450). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website legacypharma.com.
Company details
CIN U24290PN2016PTC158159
Registration Number 158159
Incorporation Date 29 January 2016
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0214450
Key People
Dhananjay Dattatray Kulkarni Additional Director Ram Appasaheb Magar Additional Director Nilesh Sharadrao Aparajit Director Recognitions & Rankings of Legacy Pharmaceuticals
Contact details
Legacy Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its website is legacypharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressS No 166 Gajanan Nagar Phursungi, Pune, Maharashtra, India – 412307
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Legacy Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Legacy Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Legacy Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Legacy Pharmaceuticals Private Limited, buy the company report.
Financials of Legacy Pharmaceuticals Private Limited
FY 2025 filings availableLegacy Pharmaceuticals Private Limited reported revenue of ₹4.62 Cr (up 11% YoY) for FY 2024.
Revenue · FY 2024
₹4.62 Cr ▲ 11%
Net profit · FY 2024
₹17.22 Lakh margin 3.7%
EBITDA · FY 2024
₹28.64 Lakh margin 6.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 39%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 130%
3 years · compounded
▲ 40%
5 years · compounded
▲ 80%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 11% growth in the latest year. EBITDA rose 130% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Legacy Pharmaceuticals Private Limited, buy the company report.
Board of directors of Legacy Pharmaceuticals Private Limited
Legacy Pharmaceuticals has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhananjay Dattatray Kulkarni | Additional Director | 10 Jun 2021 | 5 Years 4 Months | Current |
| Ram Appasaheb Magar | Additional Director | 20 Sep 2024 | 2 Years 1 Months | Current |
| Nilesh Sharadrao Aparajit Also directs: A & G Distributors Private Limited | Director | 29 Jan 2016 | 10 Years 9 Months | Current |
Peer comparison
Legacy Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Legacy Pharmaceuticals Private Limitedthis company | ₹4.62 Cr (FY 2024) | ₹17.22 Lakh | 3.7% | 11.0% | 29 | Pune, Maharashtra, India |
| STG Lifesciences Private Limited | ₹4.62 Cr (FY 2025) | -2.0% | Nagpur, Maharashtra, India | |||
| Edjen Research Labs Limited | ₹4.61 Cr (FY 2025) | 22.0% | Ghaziabad, Uttar Pradesh, India | |||
| B.M.-Prem Medicare and Pharmaceuticals Private Limited | ₹4.61 Cr (FY 2025) | 837.0% | Agra, Uttar Pradesh, India |
To see the full peer comparison of Legacy Pharmaceuticals Private Limited, buy the company report.
Auditor
Legacy Pharmaceuticals Private Limited is audited by PRASHANT GHAVATE & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRASHANT GHAVATE & ASSOCIATES | FY 2021 | 137807W |
Shareholding
The shareholding of Legacy Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Legacy Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Sep 2024 | 100979576 | Others | ₹1.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Legacy Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Legacy Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Legacy Pharmaceuticals Private Limited has a workforce of 29 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
Employee count
29
Active EPFO establishments
1
Employee growth
-3.33%
GST
Legacy Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCL0415G1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Legacy Pharmaceuticals Private Limited, buy the company report.
Recent activity
Legacy Pharmaceuticals Private Limited has 10 board changes on record since 2016: 3 appointments and 7 cessations. The latest: Ram Appasaheb Magar was appointed as Additional Director on 20 Sep 2024.
AGM
Legacy Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Legacy Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Ram Appasaheb Magar was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 150.00 Lakh with Charge ID 100979576 was registered on 04 Sep 2024.
Ceased
Santosh Ashokkumar Totla ceased to be Additional Director.
Ceased
Ram Appasaheb Magar ceased to be Director.
Appointed
Dhananjay Dattatray Kulkarni was appointed as Additional Director.
Ceased
Madhuri Santosh Jagtap ceased to be Additional Director.
Ceased
Ashok Gaikwad Madhav ceased to be Additional Director.
Ceased
Dattatray Bhivsen Dukare ceased to be Additional Director.
Ceased
Gajanan Mohaniraj Kashid ceased to be Additional Director.
Ceased
Santosh Ankush Pathare ceased to be Additional Director.
2 earlier events are in the company report.
Frequently asked questions
Legacy Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 January 2016 (10+ years old) and is registered under CIN U24290PN2016PTC158159.
Legacy Pharmaceuticals has 3 current directors:
- Dhananjay Dattatray Kulkarni - Additional Director
- Ram Appasaheb Magar - Additional Director
- Nilesh Sharadrao Aparajit - Director
The latest financial statements of Legacy Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Legacy Pharmaceuticals is 27AADCL0415G1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Legacy Pharmaceuticals is U24290PN2016PTC158159. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Legacy Pharmaceuticals was incorporated on 29 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Legacy Pharmaceuticals by revenue are STG Lifesciences Private Limited, Edjen Research Labs Limited, B.M.-Prem Medicare and Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ram Appasaheb Magar was appointed as Additional Director on 20 Sep 2024. Santosh Ashokkumar Totla ceased to be Additional Director on 25 Mar 2024. Ram Appasaheb Magar ceased to be Director on 21 Feb 2024. Legacy Pharmaceuticals has 10 board changes on record in total.
Yes, Legacy Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0214450).
Legacy Pharmaceuticals can be reached through the website legacypharma.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Legacy Pharmaceuticals is at S No 166 Gajanan Nagar Phursungi, Pune, Maharashtra, India – 412307.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages